Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
MRK Stock Up Nearly 14% So Far This Week: What's Driving It?
11:11am, Friday, 03'rd Oct 2025
Merck shares climb nearly 14% as Pfizer's landmark drug pricing deal with the Trump administration sparked renewed optimism in pharma stocks.
The 5 Highest-Yielding Dogs of the Dow Are Among Our Top Q4 Picks
03:15pm, Thursday, 02'nd Oct 2025
The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
11:37am, Thursday, 02'nd Oct 2025
Verizon (VZ -1.25%) is currently the highest-yielding stock in the Dow Jones Industrial Average (DJINDICES: ^DJI), and it isn't even close. The wireless carrier is shelling out 6.3% of its market cap
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
10:31am, Thursday, 02'nd Oct 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?
10:01am, Thursday, 02'nd Oct 2025
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ABBV Stock vs. Eli Lilly & Merck
08:20am, Thursday, 02'nd Oct 2025
AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision
Top 10 High-Yield Dividend Stocks For October 2025
02:23pm, Wednesday, 01'st Oct 2025
The October 2025 high-yield dividend watchlist highlights 10 stocks with an average forward yield of 3.95% and a projected 19.02% return. This month's selection process lowered the yield threshold to
Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30
06:45am, Wednesday, 01'st Oct 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30.
S&P 500 Gains and Losses Today: Pfizer and Merck Jump; Payments Stocks Decline
04:55pm, Tuesday, 30'th Sep 2025
An agreement with the U.S. government and a favorable regulatory decision in Europe helped lift shares of large drugmakers. Meanwhile, the announcement of a collaboration that will integrate shopping
3 Pharma Stocks Getting an Intraday Trump Bump
03:19pm, Tuesday, 30'th Sep 2025
Pharmaceutical stocks are enjoying tailwinds today, after President Donald Trump announced the launch of a direct-to-consumer website dubbed "TrumpRX.
7 Ideal "Safer" Dividend Buys From 61 September Graham Value All-Stars (GVAS)
12:16pm, Tuesday, 30'th Sep 2025
The article analyzes Large Cap Value (GASV) stocks using YCharts' Value Score and the Ben Graham Formula to identify fair-priced, high-yield dividend opportunities. Seven of fourteen 'safer' lowest-pr
Merck: Initiating "Strong Buy" On Shift To Qlex SC Injection For Solid Tumors
09:53am, Tuesday, 30'th Sep 2025
Merck earns a "Strong Buy" rating due to strategic moves, including FDA approval of QLEX, the first subcutaneous immune checkpoint inhibitor. QLEX extends Keytruda's patent life, offering rapid, flexi
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR™ (sotaterce
JP Morgan Says Stock Market Expensive: 5 Strong Buy Safe Dividend Stocks
03:45pm, Saturday, 27'th Sep 2025
Markets often rally in anticipation of rate cuts but then decline when those cuts are implemented.
Merck (MRK) Outperforms Broader Market: What You Need to Know
06:46pm, Friday, 26'th Sep 2025
In the closing of the recent trading day, Merck (MRK) stood at $78.56, denoting a +1.24% move from the preceding trading day.
